Welcome to LookChem.com Sign In|Join Free

CAS

  • or

774-52-7

Post Buying Request

774-52-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

774-52-7 Usage

Type

Synthetic compound.

Use

Induce Parkinson's disease-like symptoms in animal models for scientific research.

Toxicity

Potent neurotoxin.

Effects on the brain

Causes irreversible damage to the dopaminergic system.

Symptoms

Tremors, rigidity, and bradykinesia (slowness of movement).

Metabolism

Metabolized in the body to form MPP+.

Active toxic agent

MPP+ disrupts mitochondria and leads to cell death.

Significance

Discovery of MPTP's ability to induce Parkinson's-like symptoms has advanced our understanding of the disease and contributed to the development of new treatments and therapies.

Check Digit Verification of cas no

The CAS Registry Mumber 774-52-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,7 and 4 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 774-52:
(5*7)+(4*7)+(3*4)+(2*5)+(1*2)=87
87 % 10 = 7
So 774-52-7 is a valid CAS Registry Number.
InChI:InChI=1/C12H17N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-6,12H,7-10H2,1H3

774-52-7Relevant articles and documents

Iron-Catalyzed Methylation Using the Borrowing Hydrogen Approach

Polidano, Kurt,Allen, Benjamin D. W.,Williams, Jonathan M. J.,Morrill, Louis C.

, p. 6440 - 6445 (2018/07/25)

A general iron-catalyzed methylation has been developed using methanol as a C1 building block. This borrowing hydrogen approach employs a Kn?lker-type (cyclopentadienone)iron carbonyl complex as catalyst (2 mol %) and exhibits a broad reaction scope. A variety of ketones, indoles, oxindoles, amines, and sulfonamides undergo mono- or dimethylation in excellent isolated yields (>60 examples, 79% average yield).

NOVEL INHIBITORS

-

Page/Page column 132-133, (2011/05/03)

The invention relates to novel pyrrolidine derivatives of formula (I): wherein R1, R2 and R3 are as defined herein, as inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5). QC catalyzes the intramolecular cyclization of N-terminal glutamine residues into pyroglutamic acid (5-oxo-prolyl, pGlu*) under liberation of ammonia and the intramolecular cyclization of N-terminal glutamate residues into pyroglutamic acid under liberation of water.

The prediction of1H chemical shifts in amines: A semiempirical and ab initio investigation

Basso, Ernani A.,Gauze, Gisele F.,Abraham, Raymond J.

, p. 749 - 757 (2008/03/14)

Twenty one conformationally fixed amines and their N,N-dimethyl derivatives were obtained commercially or synthesized. These included cis and trans 4-o-butyl cyclohexylamine, 2-exo and 2-endo norbornylamine, 2-adamantylamine, 4-phenylpiperidine, 1-napthyl

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 774-52-7